Clinical Trials
8 trialsNCT06488716 2025-12-24
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7759065 as a Single Agent and in Combination With Atezolizumab in Patients With Locally Advanced or Metastatic Solid Tumors
Genentech, Inc.
Phase 1 Terminated
NCT04958226 2024-01-25
A Study to Assess the Effect of Capivasertib on Midazolam in Patients With Advanced Solid Tumours
AstraZeneca
Phase 1 Completed
NCT04121910 2020-01-23
A Study to Evaluate the Amount of Drug That Becomes Available in the Blood Circulation When Savolitinib is Administered Alone and in Combination With Itraconazole
AstraZeneca
Phase 1 Completed
NCT02086721 2017-05-31
L19-IL2
Maastricht Radiation Oncology
Phase 1 Completed
NCT01516645 2017-03-16
Phase 1 Study of KHK2898 in Subjects With Advanced Solid Tumors
Kyowa Kirin Co., Ltd.
Phase 1 Terminated
NCT01627990 2015-07-24
Nivestimâ„¢ in Treatment of Malignant Diseases
Hospira, now a wholly owned subsidiary of Pfizer
Completed
NCT01226407 2012-12-31
Examine Maximum Tolerated Dose and Pharmacokinetic and Pharmacodynamic Profile
CrystalGenomics, Inc.
Phase 1 Unknown
NCT01300468 2011-02-21
Study of PHA-848125AC in Adult Patients With Advanced/Metastatic Solid Tumors
Nerviano Medical Sciences
Phase 1 Completed